Literature DB >> 31493384

On-site stereomicroscope quality evaluations to estimate white core cutoff lengths using EUS-FNA biopsy sampling with 22-gauge needles.

Hironori Masutani1, Kosuke Okuwaki1, Mitsuhiro Kida1, Tsutomu Yoshida2, Hiroshi Imaizumi1, Hiroshi Yamauchi1, Tomohisa Iwai1, Toru Kaneko1, Rikiya Hasegawa1, Eiji Miyata1, Wasaburo Koizumi1.   

Abstract

BACKGROUND AND AIMS: Although rapid on-site cytologic evaluation (ROSE) during EUS-guided FNA biopsy (EUS-FNAB) sampling may improve accuracy of pathologic analyses, cytopathologists are not widely available. We calculated the cutoff lengths required for accurate pathologic diagnoses from stereomicroscopically visible white cores (SVWCs) sampled using 22-gauge needles.
METHODS: Overall, 118 patients with mediastinal or upper abdominal solid masses requiring pathologic diagnoses were included. EUS-FNAB sampling was performed using 22-gauge needles. SVWCs were isolated and measured using stereomicroscopy, and the utility of calculated cutoff lengths in diagnosis was investigated.
RESULTS: The procedure success and SVWC sampling rates were both 100%, and the median SVWC length was 10 mm. Pathologic examination identified 75, 31, and 12 patients with pancreatic neoplasms (PNs), subepithelial lesions (SELs), and other lesions, respectively. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for diagnosing malignancy using EUS-FNAB sampling were 93.1%, 100%, 100%, 69.6%, and 94%, respectively. The final diagnostic accuracy in the entire cohort, PNs, and SELs was 92.4%, 90.7%, and 93.5%, respectively. Receiver operating characteristic curves demonstrated the overall SVWC cutoff length to be 11 mm (11 mm for PNs, 3.5 mm for SELs). The overall sensitivity according to SVWC cutoff length was 91.4% (87.6% for PNs, 98.8% for SELs). Compared with cutoff length, multivariate analysis confirmed SVWC length to be a stronger independent factor for tissue diagnosis in both groups.
CONCLUSIONS: Diagnosis improved significantly with SVWC cutoff lengths ≥11 mm. This may be a useful index for endoscopists, particularly where ROSE is unavailable. (Clinical trial registration number: UMIN000023013.).
Copyright © 2019 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31493384     DOI: 10.1016/j.gie.2019.08.033

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  4 in total

1.  Usefulness of the automated multiband imaging system for EUS-FNA biopsy specimen evaluation in patients with upper gastrointestinal subepithelial lesions.

Authors:  Kosuke Okuwaki; Hiroshi Imaizumi; Mitsuhiro Kida; Hironori Masutani; Tomohisa Iwai; Masafumi Watanabe; Kai Adachi; Masayoshi Tadehara; Rikiya Hasegawa; Seigo Nakatani; Takahiro Kurosu; Akihiro Tamaki; Wasaburo Koizumi
Journal:  Endosc Ultrasound       Date:  2022-03-21       Impact factor: 5.275

2.  Pancreatic Schwannoma Diagnosed by Endoscopic Ultrasound-guided Fine-needle Aspiration.

Authors:  Taro Hanaoka; Kosuke Okuwaki; Hiroshi Imaizumi; Yusuke Imawari; Tomohisa Iwai; Hiroshi Yamauchi; Rikiya Hasegawa; Kai Adachi; Masayoshi Tadehara; Takahiro Kurosu; Masafumi Watanabe; Akihiro Tamaki; Mitsuhiro Kida; Wasaburo Koizumi
Journal:  Intern Med       Date:  2020-11-30       Impact factor: 1.271

3.  Diagnostic efficacy of white core cutoff lengths obtained by EUS-guided fine-needle biopsy using a novel 22G franseen biopsy needle and sample isolation processing by stereomicroscopy for subepithelial lesions.

Authors:  Kosuke Okuwaki; Hironori Masutani; Mitsuhiro Kida; Hiroshi Yamauchi; Tomohisa Iwai; Eiji Miyata; Rikiya Hasegawa; Toru Kaneko; Hiroshi Imaizumi; Masafumi Watanabe; Takahiro Kurosu; Masayoshi Tadehara; Kai Adachi; Akihiro Tamaki; Wasaburo Koizumi
Journal:  Endosc Ultrasound       Date:  2020 May-Jun       Impact factor: 5.628

4.  New image-processing technology for endoscopic ultrasound-guided fine-needle aspiration biopsy specimen evaluation in patients with pancreatic cancer.

Authors:  Kosuke Okuwaki; Hiroshi Imaizumi; Mitsuhiro Kida; Hironori Masutani; Masafumi Watanabe; Kai Adachi; Masayoshi Tadehara; Akihiro Tamaki; Tomohisa Iwai; Hiroshi Yamauchi; Rikiya Hasegawa; Toru Kaneko; Takahiro Kurosu; Wasaburo Koizumi
Journal:  DEN open       Date:  2021-06-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.